5 Ways to Speed Up Your IRB Approval Process

5 Ways to Speed Up Your IRB Approval Process

For clinical researchers, sponsors, and academic institutions, time is one of the most valuable commodities. Every day spent waiting for Institutional Review Board (IRB) approval represents delayed data collection, postponed patient enrollment, and increased operational costs. While IRB review is a critical safeguard for research participants, it doesn't have to be a bottleneck that derails your entire study timeline.

Understanding typical IRB timelines is the first step, but implementing strategies to accelerate the process is where you'll see real results. Here are five proven ways to speed up your IRB approval process without compromising on quality or compliance.

1. Submit a Complete, High-Quality Application the First Time

The single most effective way to accelerate IRB approval is to avoid the back-and-forth that comes with incomplete or poorly prepared submissions. When an IRB reviewer encounters missing documents, unclear protocols, or inconsistent information, they must request revisions—a process that can add weeks or even months to your timeline.

What Makes a Complete Submission?

A comprehensive IRB submission package should include:

• A detailed, well-written protocol that clearly articulates your research question, methodology, participant population, and safety measures
• An informed consent document that is readable, comprehensive, and appropriate for your participant population
• Complete investigator documentation including CVs, training certifications, and conflict of interest disclosures
• Study-specific materials such as questionnaires, recruitment materials, data collection instruments, and device specifications
• Regulatory documentation including IND or IDE numbers (if applicable), sponsor authorization letters, and FDA correspondence

Practical Tips for Quality Submissions

Before hitting submit, conduct an internal quality review:

• Cross-check consistency: Ensure that participant numbers, study duration, and procedures are identical across all documents
• Review for completeness: Use a comprehensive IRB submission checklist to verify you haven't missed critical components
• Have a colleague review: Fresh eyes often catch issues you've overlooked
• Address known concerns proactively: If your study involves vulnerable populations, novel procedures, or significant risks, address these upfront with detailed safety and monitoring plans

By investing time in preparation, you can often reduce a multi-round review process to a single review cycle.

2. Determine if Your Study Qualifies for Expedited Review

Not all research requires full board review. Many studies qualify for expedited review, which can reduce approval timelines from weeks to just days.

Understanding Expedited Review Eligibility

Expedited review is available for research involving no more than minimal risk and falling into specific categories defined by federal regulations. Common examples include:

• Collection of biological specimens by non-invasive means
• Collection of data through noninvasive procedures routinely employed in clinical practice
• Research on individual or group characteristics using existing data, documents, or specimens
• Continuing review of research previously approved by a convened IRB where the research remains eligible for expedited review

Learn more about who qualifies for expedited IRB review and how to structure your application to take advantage of this accelerated pathway.

Maximizing Your Expedited Review Chances

If your research is on the borderline of expedited eligibility:

• Minimize risk where possible: Consider whether procedures can be modified to reduce participant risk without compromising scientific integrity
• Provide clear risk assessments: Demonstrate why the research presents no more than minimal risk
• Reference precedent: If similar studies have received expedited review, mention this in your cover letter

Expedited review can be a game-changer, particularly for time-sensitive research or pilot studies.

3. Choose the Right IRB for Your Study Type

Not all IRBs are created equal. The right IRB partner can dramatically impact your approval timeline, particularly for specialized research.

Match IRB Expertise to Your Research

Different IRBs have varying levels of experience with different research types:

• Commercial IRBs often have streamlined processes for industry-sponsored trials and regulatory expertise for FDA-regulated research
• Academic IRBs may be more familiar with social-behavioral research and investigator-initiated studies
• Specialized IRBs develop deep expertise in specific areas like medical device trials, dietary supplement research, or decentralized clinical trials

When an IRB regularly reviews protocols similar to yours, reviewers are more familiar with the regulatory landscape, common risk mitigation strategies, and industry standards—all of which contribute to faster, more informed reviews.

Consider Central IRB for Multi-Site Studies

For multi-site research, using a central or single IRB can dramatically reduce timeline complexity. Rather than navigating multiple local IRBs with different requirements, processes, and timelines, a central IRB approach provides:

• Unified review timeline: One approval instead of multiple sequential reviews
• Consistent interpretation: A single set of requirements applied across all sites
• Reduced administrative burden: One submission, one set of revisions, one approval letter

The NIH single IRB mandate has made this approach not just advantageous but required for many federally-funded multi-site studies.

4. Proactively Address Common Rejection Reasons

Many IRB submissions are delayed or rejected for predictable, preventable reasons. By anticipating and addressing these issues before submission, you can avoid costly delays.

Most Common Issues That Slow Approval

Understanding common IRB rejection reasons allows you to avoid them proactively:

Informed Consent Problems: - Consent forms written at too high a reading level (aim for 8th-grade level) - Missing required elements like confidentiality limitations or compensation details - Insufficient information about risks, alternatives, or voluntary nature of participation

Protocol Deficiencies: - Inadequate safety monitoring plans for higher-risk research - Unclear inclusion/exclusion criteria that could lead to inappropriate enrollment - Missing data and safety monitoring board (DSMB) plans for interventional trials with more than minimal risk

Regulatory Gaps: - Missing HIPAA authorization language or waivers - Incomplete investigator qualifications or training documentation - Lack of required sponsor authorization or regulatory correspondence

Pre-Submission Strategies

Before submitting:

• Use IRB templates: Many IRBs provide protocol and consent templates that incorporate required elements
• Review recent FDA guidance: Ensure your approach aligns with current regulatory expectations
• Include a cover letter: Highlight any unusual aspects of your study and explain your rationale for key decisions
• Request pre-review consultation: Some IRBs offer pre-submission consultations to identify potential issues

5. Maintain Open Communication with Your IRB

The IRB review process doesn't have to be a black box. Establishing clear, proactive communication can prevent misunderstandings and accelerate resolution of issues.

Before Submission

• Schedule a pre-submission consultation: For complex or novel research, a brief discussion with IRB staff can identify potential concerns and streamline your submission
• Ask about current workload: Understanding the IRB's review schedule can help you time your submission strategically
• Clarify review type: Confirm whether your study qualifies for expedited review or requires full board consideration

During Review

• Respond promptly to requests: When the IRB requests clarifications or revisions, respond quickly with complete information
• Be available for questions: Ensure contact information is current and respond promptly to IRB communications
• Attend board meetings when invited: If full board review requires discussion, attending the meeting allows you to answer questions in real-time

Managing Revisions Efficiently

When revisions are requested:

• Provide a detailed response letter: Address each point systematically, indicating where changes were made
• Use track changes: Make it easy for reviewers to see exactly what you modified
• Explain rather than debate: If you disagree with a requested change, explain your scientific or ethical rationale respectfully
• Submit complete responses: Partial responses only extend the review process

The Impact of Faster IRB Approval

Reducing IRB approval timelines from months to weeks—or weeks to days—creates cascading benefits throughout your research program:

• Earlier participant enrollment: Get your study up and running while maintaining recruitment momentum
• Reduced carrying costs: Minimize the expenses of maintaining research infrastructure while waiting for approval
• Competitive advantage: In competitive research areas, faster approval can mean the difference between leading the field and playing catch-up
• Team morale: Researchers stay engaged and motivated when projects move forward efficiently
• Budget predictability: Shorter timelines mean fewer budget surprises and better resource planning

Conclusion: Speed and Quality Aren't Mutually Exclusive

Accelerating your IRB approval process doesn't mean cutting corners on participant protection or scientific rigor. By submitting complete, high-quality applications, choosing the right review pathway and IRB partner, proactively addressing common issues, and maintaining open communication, you can significantly reduce approval timelines while upholding the highest ethical standards.

The strategies outlined above represent best practices developed through thousands of successful IRB submissions across diverse research types. Implementation requires upfront investment in preparation and process, but the payoff in reduced timelines, lower costs, and smoother research operations is substantial.

Ready to Accelerate Your Research Timeline?

At Elemental IRB, we specialize in efficient, expert review across all research types—from pharmaceutical trials and medical device studies to dietary supplement research and decentralized trials. Our experienced team understands that your time matters, and we've built our processes around delivering thorough, compliant reviews without unnecessary delays.

Contact Elemental IRB today to learn how our streamlined review process, responsive communication, and deep regulatory expertise can help you move from protocol to participant enrollment faster than you thought possible.